Skip to main content
The FiscalWire

ALGS

NASDAQ-CM

Aligos Therapeutics, Inc. Common Stock

$4.86
-0.53 (-9.83%)

ALGS Price Chart

Price Chart

ALGS Key Statistics

Key financial metrics and statistics for ALGS stock including valuation ratios, earnings data, ownership breakdown, and technical indicators.
IndexNASDAQP/E-EPS (ttm)-7.31Insider Own22.29%Shs Outstand5.44MPerf Week-8.99%
Market Cap30.35MForward P/E-EPS next Y-Inst Own36.71%Shs Float4.85MPerf Month-6.00%
Income-73,146,535PEG-EPS this Y90.59%Short Float14.61%Short Ratio8.49Perf Quart-7.95%
Sales31.61MP/S0.96EPS next Y%-5.18%ROA-75.57%52W High$13.69 -64.50%Perf Half Y-27.25%
Book/sh5.11P/B0.95EPS next 5Y0.01%ROE-113.59%52W Low$3.98 22.11%Perf Year-53.76%
Cash/sh4.87P/FCF-EPS past 5Y-Gross Margin96.58%Volatility7.81% 7.50%Beta2.41
Dividend-EV/EBITDA-Sales past 5Y-Oper. Margin-250.63%ATR (14)0.40Target Price$52.38
Dividend %-EV/Sales-Sales Q/Q2778.55%Profit Margin-241.01%RSI (14)34.85Avg Volume83.45K
Employees82Quick Ratio2.19EPS Q/Q90.59%SMA20-10.74%Rel Volume0.81Prev Close$5.39
Payout-Current Ratio2.19Earnings-SMA50-18.23%Volume67.55KPrice$4.86
Recom1.00Debt/Eq0.00Analysts-SMA200-24.69%-Change-983.00%

Recent News: ALGS